Relative Weakness in the DIA Signaled Trouble Early

 

Today was a great example of how effective relative strength analysis can be when trading the indices. Above is a 5-minute chart of the DIA, with the SPY shown in the lower pane for comparison. Around 12:00 ET, the market sent a very clear message if you knew where to look. While the SPY was pushing to new intraday highs, the DIA was unable to confirm that strength and instead was making a much lower high.

That divergence is classic relative weakness. When the broader market is strong and one index lags, it often signals distribution under the surface. In this case, the weakness in the Dow Jones Industrial stocks stood out clearly. Money simply was not flowing into those names the way it was into the broader market, and price was telling that story well before any major move unfolded.

As the session progressed, the DIA eventually broke its intraday low, which acted as support. Once that level gave way, the selling pressure increased and the DIA continued trending lower into the close. There was no need to predict or guess. The relative weakness had already done the heavy lifting by identifying where the market was vulnerable.

This is why I rely so heavily on relative strength and relative weakness in my trading. It helps filter out noise and keeps me focused on where money is actually moving. Days like today are a reminder that price relationships between markets often matter more than headlines or indicators. When one index can’t keep up with another, it’s usually worth paying attention.

For more analysis and market insights, visit my homepage 

. Relative Weakness Exposed the XHB Short Before the News

 

Today was a great example of how relative weakness can tip you off to a short trade before the news ever hits the tape. Above is a 5-minute chart of XHB, the homebuilders ETF, with the SPY shown in the lower pane for comparison. Around 12:20 ET, something important stood out to me in real time. The SPY was pushing to new intraday highs, yet XHB was doing the exact opposite, it was putting in a lower high. That divergence immediately caught my attention.

When the broader market is strong and a sector can’t keep up, that’s relative weakness, plain and simple. It tells you money is quietly moving out, even if prices haven’t fully broken down yet. I saw it as it was unfolding, but I didn’t take the trade because I don’t actively day trade the homebuilders. Still, the message was clear: XHB was not confirming the market’s strength.

About ten minutes later, around 12:30 ET, the catalyst arrived. News broke that President Trump was taking steps toward banning large institutional investors from buying additional single-family homes. Almost instantly, homebuilding stocks sold off hard. Once XHB broke support, the selling accelerated and the move lower became decisive.

This is why I put so much emphasis on viewing the market through the lens of relative strength and relative weakness. It often reveals what the so-called smart money or large traders are doing well before the headlines appear. Were traders positioning themselves ahead of the news, and did that show up as relative weakness? Or was it all just coincidence? I’ll let you decide.

What I do know is that when I stick to relative strength analysis, I consistently find myself aligned with the right side of the market and days like today only reinforce why I trust this approach.

For more analysis and market insights, visit my homepage 

MSOS Drifts Lower as the Market Shrugs Off Drug Czar News

 

Today was another one of those frustrating, low energy days for MSOS. Price action was dull, volume was uninspiring, and to make matters worse the ETF drifted slightly lower. That’s annoying for me personally because I’ve been stalking long setups for several days now and nothing is triggering. No clean breakouts, no decisive reversals just a lot of waiting. From my perspective, the line in the sand remains very clear: I want to see MSOS get back above $5. Until that happens, I’m not convinced we’ve truly turned the corner and are ready for a sustained move higher.

What made today more interesting or at least confusing was the news that hit around 2:00 PM. The Senate officially confirmed President Donald Trump’s pick for White House drug czar, Sara Carter Bailey, who will serve as director of the Office of National Drug Control Policy. Given her publicly stated stance on cannabis, I honestly expected the market to react more positively. Instead, we got a brief blip higher that quickly faded, followed by selling into the close.

That reaction tells me a lot. On paper, this should have been supportive news for the sector. Carter has been fairly pragmatic and open-minded when it comes to cannabis policy. She has explicitly supported medical cannabis, stated that she doesn’t have a “problem” with legalization even if she doesn’t personally advocate for it, and has described cannabis reform as a bipartisan issue. She’s also acknowledged that the administration kept all options on the table regarding rescheduling and didn’t push back when questioned by Senator Cory Booker about expanded research and reform. That’s about as reasonable a stance as you can hope for from someone in that role.

Yet the market shrugged it off. To me, that suggests either the news was already priced in, or more likely, that traders are still skeptical and want to see actual price confirmation, not just headlines. This is why I always come back to relative strength and price behavior. If the sector were truly under accumulation, we’d see it respond better to news like this.

For now, it’s still a waiting game. I remain interested, I remain constructive longer-term, but until MSOS proves itself by reclaiming key levels, patience is the only trade. Let’s see what tomorrow brings.

For more analysis and market insights, visit my homepage 

TSLA Underperforms as the Market Rallies: A Case Study in Relative Weakness

 

What is going on with TSLA? That’s the question I kept asking myself today as I watched a very strong overall market continue to push higher while TSLA struggled yet again. Day after day we’ve seen strength across the indices, yet TSLA has consistently failed to participate, and today was no different.

Above is a 3-minute chart of TSLA, and in the lower pane I’m using a 3-minute chart of SPY for comparison. When I line these two up, the divergence becomes obvious. From point A to point B on the SPY, the S&P 500 is clearly trending higher, making strong, decisive highs. In a healthy market environment like this, you would normally expect leadership stocks or at least widely followed names like TSLA to mirror that strength. But that simply didn’t happen.

Instead, TSLA made a much lower high at point B compared to point A. While the market was pushing forward, TSLA was already rolling over. That’s classic relative weakness, and it immediately put TSLA on my radar. This wasn’t subtle either. The market was sending one message, and TSLA was sending the exact opposite.

One of the things I love most about analyzing the market through the lens of relative strength or in this case relative weakness, is how consistent it is across timeframes. It really doesn’t matter whether I’m looking at a 1-minute chart, 2-minute, 3-minute, 5-minute, or even a 10-minute chart. That divergence is still there. The story doesn’t change. TSLA is underperforming SPY, regardless of the timeframe you choose.

That consistency is a breath of fresh air compared to traditional indicators like moving averages or oscillators. Those tools often give you completely different signals depending on the arbitrary timeframe you happen to be looking at. One chart might say buy, another might say sell, and suddenly you’re second-guessing everything. Relative strength cuts through that noise. If a stock is weak relative to the market, it stays weak no matter how you slice the timeframe.

Once the divergence in TSLA was identified, the next key moment was the break of support. When that level gave way, it confirmed what the relative weakness had already been telling us. From there, TSLA proceeded to move lower all the way down to point C, even as the broader market remained strong.

To me, this was just a textbook example of how relative weakness can work even in a strong tape. The market doesn’t need to be falling for individual stocks to break down. Money rotates, leaders change, and TSLA showed very clearly today that it was not where capital wanted to be.

For more analysis and market insights, visit my homepage 

NVDA vs SPY: Why This Divergence Warrants Caution

 Above is a 60-minute chart of NVDA, and in the lower pane I’m comparing it to the SPY using a relative strength ratio. What stands out to me is the clear divergence we saw today. The S&P 500 pushed to a new high, yet NVDA failed to do the same. That alone gets my attention, especially given how closely NVDA has tracked the broader market during strong momentum phases in the past.

Over the last six trading days, NVDA has essentially gone nowhere. On its own, a consolidation isn’t necessarily bearish. In strong trends, pauses are healthy. However, when I zoom out and view this action through the lens of relative strength, the picture starts to change.

During this consolidation, the relative strength line is making a new low before price does. That’s an important detail. When the ratio breaks down ahead of price, it often tells us that money is quietly rotating out of the stock even though price hasn’t fully reflected it yet. To me, this is one of the earliest signs of relative weakness, and it’s something I take seriously especially as a short-term trader.

This doesn’t mean NVDA is suddenly a bad stock. Far from it. Long term, NVDA remains one of the strongest leadership names in the market, and I still love it from a big picture perspective. But markets are about timing, and right now the short-term risk is increasing. The market is making new highs, yet NVDA is lagging, and that’s not a combination I want to ignore.

The key level I’m watching is support at 185.91. That level represents the most recent area where buyers stepped in. If price breaks below that support, it would confirm the weakness already showing up in the relative strength line. At that point, the odds would favor further downside, and the caution I’m feeling now would be validated.

Until that happens, I’m staying patient. As long as NVDA holds above 185.91, I’m not interested in shorting it. I don’t want to front-run a breakdown. For now, this is a stock on my watchlist not for new longs, not for shorts yet but as a name that may be transitioning from leadership to laggard if this relative weakness continues.

For more analysis and market insights, visit my homepage